Tiny Heart-Vibration patch could predict surgery risks in oesophageal cancer
NCT ID NCT07159711
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a small device called Seismofit that sticks to the chest and measures heart vibrations to estimate fitness in under three minutes. Researchers want to see if it can predict complications like pneumonia and hospital stay length in 164 oesophageal cancer patients undergoing chemotherapy and surgery. The device is compared to the standard hour-long exercise test to see if it is accurate enough for routine use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Seismofit device (a small chest patch that measures heart vibrations to estimate fitness)
What this could lead to
If successful, this could provide a quick, simple way to assess fitness and predict complications in oesophageal cancer patients, helping doctors tailor treatment.
What could go wrong
This is an early-stage study with only 164 participants, and the device has not been tested in this patient group before. It may not accurately predict outcomes or replace standard tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••